Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Stealth BioTherapeutics
Stealth BioTherapeutics
Verge Genomics and Stealth Bio Advance Novel Therapeutics in ALS
BioSpace
Wed, 11/2/22 - 10:05 am
ALS
Verge Genomics
Stealth BioTherapeutics
clinical trials
VRG50635
SBT-272
FDA Agrees to Meet with Stealth on Barth Syndrome Drug
BioSpace
Tue, 06/14/22 - 11:20 am
Stealth BioTherapeutics
FDA
Barth Syndrome
elamipretide
FDA shoots down a biotech’s last-stand patient pitch after faulting data
Endpoints
Wed, 10/20/21 - 10:29 am
Stealth BioTherapeutics
FDA
Barth Syndrome
elamipretide
The FDA wants more data. Stealth is filing for approval anyway
Fierce Biotech
Tue, 08/24/21 - 10:45 am
Stealth BioTherapeutics
elamipretide
FDA
clinical trials
Barth Syndrome
Stealth Bio Faces Setback in Failed Mitochondrial Disease Trial
BioSpace
Fri, 12/20/19 - 08:16 pm
Stealth BioTherapeutics
elamipretide
mitochondrial myopathy
clinical trials
Alexion bags option on Stealth's phase 3 rare disease drug
Fierce Biotech
Thu, 10/10/19 - 07:58 pm
Alexion
Stealth BioTherapeutics
clinical trials
mitochondrial myopathy
elamipretide
Stealth Bio prices $78M IPO at bottom end of range
BioCentury
Fri, 02/15/19 - 10:12 am
Stealth BioTherapeutics
IPOs
mitochondrial disorders
Another IPO frenzy? Two US biotechs head to Hong Kong for a public market debut
Endpoints
Thu, 07/5/18 - 09:50 am
Hong Kong
IPOs
biotech
Stealth BioTherapeutics
AOBiome